Today’s top gainers include the company CR Bard Inc. (NYSE:BCR) which is in the industry Medical Instruments & Supplies, gaining 0.75% today. In the last week its performance is 4.05%, and 15.43% for the past quarter. Currently, CR Bard Inc., BCR has a target price of 229.64, so today’s gain of 0.75% is a significant step towards its target price. The GAP today is therefore -0.07%.
CR Bard Inc. (NYSE:BCR), has a market cap of 17395.9, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 90.70%.
At the current price of 238.62, it has a dividend yield of 0.44%, and its target price is 229.64. This is with a profit margin of *TBA, and total debt/equity of 1.14. CR Bard Inc. (NYSE:BCR) has a P/E of 104.89, as well as a forward P/E of 21.03.
With a current EPS of 2.26, and a forecasted EPS growth for next year at 10.90%,CR Bard Inc. (NYSE:BCR) has had a EPS growth for the past five years at -19.80%. For the next five years EPS growth is projected to be 10.80%.
Performance for the year is 37.90%. Since its IPO date on 04/06/1983, the total performance to date is 25.33%.
Volume today for CR Bard Inc. (NYSE:BCR), is 92112, while its average volume is 466.83. Whilst the total gain today was 0.75%, it did have a day high of 0.07%.
Volatility for this week has been at 1.34%, and 1.40% for the month. The 52-week low for CR Bard Inc., BCR has been 41.84%, while the 52-week-high has reached 0.07%.
Looking at its return of investments, which is 6.40%, and its return on assets is *TBA. CR Bard Inc. (NYSE:BCR) has an operating margin of *TBA. With a sales growth of 6.60% quarter over quarter. Bearing in mind that CR Bard Inc., BCR is in the sector Healthcare, its long-term debt/equity is 0.78, and has a current ratio of 1.5 and 1.2 for quick ratio.
So what is the value of CR Bard Inc.? Well its PEG is 9.71, and the P/S is 5.01, along with a P/B of 12. Meanwhile it has a p/cash of 22.74.